CVS Health (NYSE:CVS) Upgraded at Cantor Fitzgerald

CVS Health (NYSE:CVS) was upgraded by analysts at Cantor Fitzgerald from a “neutral” rating to an “overweight” rating in a report issued on Wednesday,Briefing.com Automated Import reports.

A number of other research firms also recently weighed in on CVS. TD Cowen raised their price objective on CVS Health from $73.00 to $80.00 and gave the company a “buy” rating in a research note on Monday, November 25th. Barclays decreased their price objective on shares of CVS Health from $75.00 to $71.00 and set an “overweight” rating on the stock in a research report on Thursday, November 7th. Edward Jones raised shares of CVS Health from a “hold” rating to a “buy” rating in a research report on Thursday, January 30th. Leerink Partners lifted their target price on shares of CVS Health from $51.00 to $55.00 and gave the company a “market perform” rating in a research note on Tuesday. Finally, Mizuho decreased their price target on shares of CVS Health from $73.00 to $66.00 and set an “outperform” rating for the company in a research note on Thursday, October 24th. One analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have given a buy rating to the company. Based on data from MarketBeat, CVS Health currently has an average rating of “Moderate Buy” and a consensus target price of $67.78.

CVS Health Stock Performance

Shares of NYSE CVS traded up $8.69 during midday trading on Wednesday, hitting $63.69. 27,272,732 shares of the company’s stock were exchanged, compared to its average volume of 12,906,413. The company’s 50 day moving average price is $50.61 and its 200 day moving average price is $55.92. CVS Health has a 12 month low of $43.56 and a 12 month high of $80.75. The firm has a market capitalization of $80.14 billion, a PE ratio of 16.22, a price-to-earnings-growth ratio of 0.60 and a beta of 0.61. The company has a quick ratio of 0.59, a current ratio of 0.80 and a debt-to-equity ratio of 0.80.

CVS Health (NYSE:CVS) last issued its earnings results on Wednesday, February 12th. The pharmacy operator reported $1.19 EPS for the quarter, topping the consensus estimate of $0.89 by $0.30. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. As a group, analysts predict that CVS Health will post 5.14 earnings per share for the current fiscal year.

Hedge Funds Weigh In On CVS Health

Several hedge funds have recently added to or reduced their stakes in the stock. Integrated Advisors Network LLC grew its position in CVS Health by 0.7% in the 3rd quarter. Integrated Advisors Network LLC now owns 27,625 shares of the pharmacy operator’s stock valued at $1,737,000 after buying an additional 200 shares during the last quarter. Widmann Financial Services Inc. increased its stake in shares of CVS Health by 1.8% during the third quarter. Widmann Financial Services Inc. now owns 11,506 shares of the pharmacy operator’s stock worth $724,000 after acquiring an additional 200 shares during the period. EagleClaw Capital Managment LLC raised its holdings in CVS Health by 3.4% during the fourth quarter. EagleClaw Capital Managment LLC now owns 6,135 shares of the pharmacy operator’s stock worth $275,000 after purchasing an additional 200 shares in the last quarter. DT Investment Partners LLC lifted its position in CVS Health by 7.8% in the third quarter. DT Investment Partners LLC now owns 2,777 shares of the pharmacy operator’s stock valued at $175,000 after purchasing an additional 202 shares during the period. Finally, Manchester Capital Management LLC increased its position in CVS Health by 4.8% during the 4th quarter. Manchester Capital Management LLC now owns 4,457 shares of the pharmacy operator’s stock worth $200,000 after purchasing an additional 204 shares during the period. 80.66% of the stock is currently owned by hedge funds and other institutional investors.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.